Mark Gorman

12.0k total citations · 1 hit paper
100 papers, 4.8k citations indexed

About

Mark Gorman is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Mark Gorman has authored 100 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 29 papers in Neurology and 13 papers in Epidemiology. Recurrent topics in Mark Gorman's work include Multiple Sclerosis Research Studies (29 papers), Autoimmune Neurological Disorders and Treatments (16 papers) and Peripheral Neuropathies and Disorders (14 papers). Mark Gorman is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), Autoimmune Neurological Disorders and Treatments (16 papers) and Peripheral Neuropathies and Disorders (14 papers). Mark Gorman collaborates with scholars based in United States, United Kingdom and Australia. Mark Gorman's co-authors include Tanuja Chitnis, Brian C. Healy, Gary H. Lyman, Mariann Polgar‐Turcsanyi, Leslie Benson, Russell C. Dale, Dominique Delbeke, James Fletcher, Norbert Avril and W. Warren Suh and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Mark Gorman

93 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations on the Use of ¹⁸F-FDG PET in Oncology

2008 790 citations James Fletcher, Benjamin Djulbegović et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Gorman United States	32	1.7k	1.7k	1.0k	608	605	100	4.8k
Karen J. Marcus United States	40	990 0.6×	1.4k 0.8×	1.1k 1.0×	433 0.7×	625 1.0×	144	5.6k
Edward Fox United States	35	3.6k 2.1×	1.5k 0.9×	1.5k 1.5×	277 0.5×	325 0.5×	156	6.0k
Naoya Nakamura Japan	38	2.6k 1.5×	723 0.4×	2.4k 2.3×	198 0.3×	466 0.8×	377	5.2k
Ephraim P. Hochberg United States	42	2.0k 1.1×	910 0.5×	1.9k 1.8×	307 0.5×	266 0.4×	148	5.2k
Kathryn Trinkaus United States	50	1.8k 1.1×	835 0.5×	2.1k 2.0×	2.4k 4.0×	733 1.2×	163	8.0k
Lorenza Gandola Italy	37	1.2k 0.7×	1.0k 0.6×	1.6k 1.5×	179 0.3×	387 0.6×	148	5.2k
J. Rosenberg United States	17	2.2k 1.3×	904 0.5×	1.2k 1.1×	1.2k 2.0×	121 0.2×	29	4.2k
Ingo Kleiter Germany	35	3.2k 1.9×	2.7k 1.6×	615 0.6×	143 0.2×	196 0.3×	121	5.0k
Timothy J. Kaufmann United States	41	1.6k 0.9×	1.6k 1.0×	368 0.4×	916 1.5×	504 0.8×	148	5.5k
Catherine A. Billups United States	48	868 0.5×	1.2k 0.8×	1.8k 1.7×	327 0.5×	298 0.5×	165	6.0k

Countries citing papers authored by Mark Gorman

Since Specialization

Citations

This map shows the geographic impact of Mark Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gorman more than expected).

Fields of papers citing papers by Mark Gorman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gorman. The network helps show where Mark Gorman may publish in the future.

Co-authorship network of co-authors of Mark Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gorman. A scholar is included among the top collaborators of Mark Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gorman. Mark Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Bo, et al.. (2024). Inaugural Patient-Reported Registry of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: Presentation, Diagnosis, and Treatment of 194 Patients. Pediatric Neurology. 158. 128–134.

Brenton, J. Nicholas, Suzan L. Carmichael, Moses Rodriguez, et al.. (2024). Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis. Multiple Sclerosis Journal. 30(8). 1056–1065.

Stredny, Coral M., et al.. (2022). Development of a multidisciplinary clinical approach for unexplained regression in Down syndrome. American Journal of Medical Genetics Part A. 188(8). 2509–2511. 2 indexed citations

Rossor, Thomas, E. Ann Yeh, Yasmin Khakoo, et al.. (2022). Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children. Neurology Neuroimmunology & Neuroinflammation. 9(3). 31 indexed citations

Stredny, Coral M., Melissa M. Blessing, Bo Zhang, et al.. (2022). Mimics of Pediatric Small Vessel Primary Angiitis of the Central Nervous System. Annals of Neurology. 93(1). 109–119. 5 indexed citations

Stredny, Coral M., et al.. (2020). Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES). SHILAP Revista de lepidopterología. 7. 2329048X2097925–2329048X2097925. 47 indexed citations

Ghezzi, Angelo, Brenda Banwell, Amit Bar‐Or, et al.. (2020). Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations. Multiple Sclerosis Journal. 27(12). 1814–1822. 22 indexed citations

Höftberger, Romana, Yong Guo, Eoin P. Flanagan, et al.. (2020). The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathologica. 139(5). 875–892. 225 indexed citations

Solomon, Isaac H., Hojun Li, Leslie Benson, et al.. (2018). Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. Journal of Neuropathology & Experimental Neurology. 77(12). 1079–1084. 19 indexed citations

10.

Wong, Sandra L., Mark B. Faries, Erin B. Kennedy, et al.. (2017). Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Annals of Surgical Oncology. 25(2). 356–377. 106 indexed citations

11.

Belman, Anita, Lauren Krupp, Cody S. Olsen, et al.. (2016). Demographic and Clinical Characteristics of 490 Children and Adolescents with Multiple Sclerosis (MS): US Network of Pediatric MS Centers’ Experience (S29.004). Neurology. 86(16_supplement). 1 indexed citations

12.

Fletcher, James, Benjamin Djulbegović, Heloisa P. Soares, et al.. (2014). Recommendations on the Use of 18F-FDG PET in Oncology.

13.

O’Rourke, Declan, Ann M. Bergin, Alexander Rotenberg, et al.. (2014). Rasmussen's encephalitis presenting as focal cortical dysplasia. Epilepsy & Behavior Case Reports. 2. 86–89. 13 indexed citations

14.

Chitnis, Tanuja, Charles R.G. Guttmann, Alexander Musallam, et al.. (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurology. 13(1). 173–173. 5 indexed citations

15.

Wong, Sandra L., Charles M. Balch, Patricia A. Hurley, et al.. (2012). Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. Journal of Clinical Oncology. 30(23). 2912–2918. 239 indexed citations

16.

Kivisäkk, Pia, Roopali Gandhi, Khadir Raddassi, et al.. (2012). Increased Th17 response to myelin peptides in pediatric MS. Clinical Immunology. 146(3). 176–184. 23 indexed citations

17.

Gorman, Mark. (2012). Daclizumab Use in Patients With Pediatric Multiple Sclerosis. Archives of Neurology. 69(1). 78–78. 30 indexed citations

18.

Waldman, Amy, et al.. (2011). Management of Pediatric Central Nervous System Demyelinating Disorders: Consensus of United States Neurologists. Journal of Child Neurology. 26(6). 675–682. 68 indexed citations

19.

Yeh, E. Ann, Emmanuelle Waubant, Lauren Krupp, et al.. (2010). Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis. Archives of Neurology. 68(4). 437–437. 87 indexed citations

20.

Gorman, Mark, Paul M. Lambert, Harold F. Morris, Shigeru Ochi, & Sheldon Winkler. (1994). THE EFFECT OF SMOKING ON IMPLANT SURVIVAL AT SECOND-STAGE SURGERY. Implant Dentistry. 3(3). 165–165. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact